Ron Bose

15.5k citations
95 papers · 6.7k · 6 hit papers · h-index 33

Impact in

  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Genomics and Diagnostics

Papers in

    • HER2/EGFR in Cancer Research 44
    • Cancer Treatment and Pharmacology 9
    • Advanced Breast Cancer Therapies 24
    • Gastric Cancer Management and Outcomes 14
    • Lung Cancer Treatments and Mutations 10

Ron Bose

91 papers receiving 6.6k citations

Ron Bose's Hit Papers

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study 2021 · 263 citations
2630+10+20Years since publication50010001.5k

Peers

Ron Bose
Comparison fields: 5 of 122
  • Oncology 2.7k
  • Cancer Research 1.1k
  • Molecular Biology 3.3k
  • Radiology, Nuclear Medicine and Imaging 885
  • Pulmonary and Respiratory Medicine 1.0k
Replace Antonella De Luca with:
Antonella De Luca Italy
Zhen Fan United States
Stephen P. Ethier United States
Tona M. Gilmer United States
Hui‐Wen Lo United States
Mark M. Moasser United States
F. Michael Yakes United States
Lori S. Friedman United States
Moorthy P. Ponnusamy United States
Sarah Bacus United States
Ron Bose relative to Antonella De Luca Italy Antonella De Luca's profile →
Citations per field
00.5×1.6×
Antonella De Luca · 1×
Citations per year

Countries citing papers authored by Ron Bose

Since Specialization
Citations

This map shows the geographic impact of Ron Bose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Bose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Bose more than expected).

Fields of papers citing papers by Ron Bose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Bose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Bose. The network helps show where Ron Bose may publish in the future.

Co-authors

The 25 scholars most cited alongside Ron Bose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ron Bose Line = papers co-authored together Ron Bose links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Hit paper breakdown →
19961612
2
Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals
Hit paper breakdown →
1995743
3
Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
Hit paper breakdown →
2012607
4
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
Hit paper breakdown →
2019387
5
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
Hit paper breakdown →
2018363
6 2007272
7
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Hit paper breakdown →
2021263
8 2016221
9 2015220
10 2006179
11 2008144
12 2016119
13 202082
14 201181
15 201867
16 201566
17 201961
18 201660
19 200860
20 201557

About Ron Bose

Ron Bose is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 95 papers that have together received 6.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (44 papers), Advanced Breast Cancer Therapies (24 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Cancer Genomics and Diagnostics (16 papers), Gastric Cancer Management and Outcomes (14 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer Treatment and Pharmacology (9 papers) and Breast Cancer Treatment Studies (8 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (1.1k citations), Molecular Biology (3.3k citations), Radiology, Nuclear Medicine and Imaging (885 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Ron Bose has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Richard Kolesnick, Marcel Verheij, Adriana Haimovitz‐Friedman, W. David Jarvis, Zvi Fuks, Michael J. Birrer, Zvi Fuks, Steven Grant, Leonard I. Zon and Xin Lin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Journal of Biological Chemistry and Journal of the National Comprehensive Cancer Network.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact